**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 74-79-3 |L-(+)-ARGININE | 98+% | 200-811-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully
investigated.Light sensitive.Moisture sensitive.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May cause erythema (redness) and edema
(fluid buildup) with crusting and scaling.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated.
Chronic:
Laboratory experiments have resulted in mutagenic effects.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Dusts at sufficient concentrations can form
explosive mixtures with air. During a fire, irritating and highly
toxic gases may be generated by thermal decomposition or combustion.
Non-combustible, substance itself does not burn but may decompose
upon heating to produce irritating, corrosive and/or toxic fumes.
Extinguishing Media:
Substance is noncombustible; use agent most appropriate to
extinguish surrounding fire. Do NOT get water inside containers. Use
water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation. Do not get water inside containers.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation. Store protected from light. Do not allow contact with
water. Keep from contact with moist air and steam.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Store
protected from moisture. Store protected from light.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 74-79-3:
Russia: 10 mg/m3 TWA
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: white
Odor: none reported
pH: 11.4
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 223-224 deg C (dec)
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 224 deg C
Solubility in water: Soluble.
Specific Gravity/Density: 1.3 (water=1)
Molecular Formula: C6H14N4O2
Molecular Weight: 174.1236
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions. Materials containing similar functional
groups can decompose at elevated temperatures.
Conditions to Avoid:
High temperatures, incompatible materials, light, dust generation,
moisture.
Incompatibilities with Other Materials:
Strong oxidizing agents, moisture.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 74-79-3: CF1934200
LD50/LC50:
Not available.
Carcinogenicity:
L-(+)-ARGININE -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 74-79-3: 0
Canada
CAS# 74-79-3 is listed on Canada's DSL List.
CAS# 74-79-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 74-79-3 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Nalpha-BOC-D-ASPARAGINE, 98%
| 75647-01-7 |
|
3-Methyl-1-butanol
| 123-51-3 |
|
N-alpha-BOC-D-Glutamine, 98%
| 61348-28-5 |
|
N-Octyl isothiocyanate
| 4430-45-9 |
|
NALPHA-BOC-D-HISTIDINE, 98%
| 50654-94-9 |
|
1,6-Hexanediamine, 60 wt % Aqueous Soln.
| 124-09-4 |
|
Isopropyl Ether
| 108-20-3 |
|
L-Alanine
| 56-41-7 |
|
alpha-Ketoglutaric Acid
| 328-50-7 |
|
L-(+)-Lysine Monohydrochloride, 99+%
| 657-27-2 |
|
BOC-D-Leucine monohydrate, 98%
| 16937-99-8 |
|
l-(+)-Glutamine, 99%
| 56-85-9 |
|
l-(+)-Arginine hydrochloride, 98+%
| 1119-34-2 |
|
l-Valine, 97% (titr.)
| 72-18-4 |
|
L-Cystine, 96% (titr.)
| 56-89-3 |
|
L-(+)-Arginine, 98+%
| 74-79-3 |
|
BOC-D-Methionine, 98%
| 5241-66-7 |
|
BOC-L-Norleucine, 98%
| 6404-28-0 |
|
BOC-L-Norvaline, 98%
| 53308-95-5 |
|
BOC-D-Proline, 98%
| 37784-17-1 |
|
l(+)-Ascorbic acid, reagent acs
| 50-81-7 |
|
L(+)-Asparagine Monohydrate, 99%
| 5794-13-8 |
|
3'-Bromopropiophenone, 98%
| 19829-98-8 |
|
Lead Nitrate, Reagent ACS (Crystals)
| 10099-74-8 |
|
L-Aspartic acid-4-(4-methyl-7-coumarinylamide)
| 133628-73-6 |
|
1-(4-Fluorophenyl)piperazine, 98%
| 2252-63-3 |
|
Lead(II) oxide, 99.7%
| 1317-36-8 |
|
Lecithin, granular
| 8002-43-5 |
|
Light Green SF, Yellowish (Cert)
| 5141-20-8 |
|
5-Bromo-6-Chloro-3-Indolyl-beta-D-Glucuronide Cyclohexylammonium Salt
| 144110-43-0 |
|
4-Nitrophenyl-N-Acetyl-??-D-Galactosaminide
| 14948-96-0 |
|
Phenyl-beta-D-Glucuronide Hydrate, 99%
| 17685-05-1 |
|
4-Methylumbelliferyl-alpha-D-Mannopyranoside Hydrate, 99%
| 28541-83-5 |
|
alpha-Terpineol
| 98-55-5 |
|
Ligroine, boiling range 35 - 60 degree C
| 8032-32-4 |
|
Lithium Bromide, 99.999%
| 7550-35-8 |
|
Phenylmagnesium chloride, 25 wt% solution in tetrahydrofuran
| 100-59-4 |
|
1-Hydroxy-9-fluorenone, 99%
| 6344-60-1 |
|
Zinc Sulfide
| 1314-98-3 |
|
Lithium Carbonate, 99%
| 554-13-2 |
|
3-Indoxyl Phosphate Disodium Salt, 99%
| 3318-43-2 |
|
Magnesium Oxide, P.A.
| 1309-48-4 |
|
6,7-Diethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinoline hydrochloride,
| 94914-42-8 |
|
Magnesium perchlorate, reagent ACS
| 10034-81-8 |
|
Magnesium Sulfate, Anhydrous, 97% (titr.)
| 7487-88-9 |
|
Magnesium sulfate heptahydrate, p.a
| 7487-88-9 |
|
n-Pentyl propionate, 99+%
| 624-54-4 |
|
Maleic Acid, 99%
| 110-16-7 |
|
Malonic acid, 99%
| 141-82-2 |
|
2-Methyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride,
| 16135-43-6 |
|
|